These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2054435)

  • 1. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
    Feldon J; Weiner I
    Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
    Weiner I; Feldon J
    Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of latent inhibition by haloperidol in rats.
    Weiner I; Feldon J
    Psychopharmacology (Berl); 1987; 91(2):248-53. PubMed ID: 3107041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.
    Weiner I; Feldon J; Katz Y
    Pharmacol Biochem Behav; 1987 Feb; 26(2):241-6. PubMed ID: 3575349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
    Feldon J; Weiner I
    Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.
    Trimble KM; Bell R; King DJ
    Pharmacol Biochem Behav; 1997 Apr; 56(4):809-16. PubMed ID: 9130309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
    Ruob C; Elsner J; Weiner I; Feldon J
    Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early handling and latent inhibition in the conditioned suppression paradigm.
    Weiner I; Feldon J; Ziv-Harris D
    Dev Psychobiol; 1987 Mar; 20(2):233-40. PubMed ID: 3582782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
    Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
    Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: implications for schizophrenia.
    De la Casa LG; Ruiz G; Lubow RE
    Biol Psychiatry; 1993 May; 33(10):707-11. PubMed ID: 8353165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.
    Solomon PR; Crider A; Winkelman JW; Turi A; Kamer RM; Kaplan LJ
    Biol Psychiatry; 1981 Jun; 16(6):519-37. PubMed ID: 7196265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.
    Weiner I; Lubow RE; Feldon J
    Psychopharmacology (Berl); 1984; 83(2):194-9. PubMed ID: 6431473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of latent inhibition in the rat at a high dose of clozapine.
    Trimble KM; Bell R; King DJ
    J Psychopharmacol; 1998; 12(2):215-9. PubMed ID: 9694034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
    Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
    Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol can increase responding to both discrete and contextual cues in trace conditioned rats.
    Cassaday HJ; Nelson AJ; Norman C
    Behav Brain Res; 2005 Mar; 158(1):31-42. PubMed ID: 15680192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses.
    Vaitl D; Lipp O; Bauer U; Schüler G; Stark R; Zimmermann M; Kirsch P
    Schizophr Res; 2002 May; 55(1-2):147-58. PubMed ID: 11955974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.